| Phil M Aldrich, MD | |
|
2874 N Carson St, Suite 200, Carson City, NV 89706-0251 | |
| (775) 445-7170 | |
| (775) 883-9059 |
| Full Name | Phil M Aldrich |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 53 Years |
| Location | 2874 N Carson St, Carson City, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275645426 | NPI | - | NPPES |
| 002013121 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 3334 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Healthy Living At Home -carson City, Llc | Carson city, NV | Home health agency |
| Kindred At Home | Galena, NV | Home health agency |
| A+ Hospice Care | Reno, NV | Hospice |
| Carson Tahoe Regional Medical Center | Carson city, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carson Tahoe Physician Clinics | 1153479027 | 83 |
News Archive
We're born with our brains prewired, but as information comes in from our environment, this circuitry is updated. A study from Boston Children's Hospital provides a new glimpse of how this happens: Brain cells known as microglia, tuned into the crosstalk between neurons, literally engulf unnecessary connections, known as synapses, and prune them away.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of EonC, the first extended-life primary cell (non-rechargeable) neurostimulator for the treatment of chronic pain.
The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
It is estimated that more than 1 billion individuals worldwide in 2005 had presbyopia, or age-related difficulty in seeing objects nearby, with an estimated 410 million with the condition unable to perform tasks requiring near vision, according to a report in the December issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
The U.N. on Tuesday said "it is running a record funding-shortfall of $4.8 billion for its aid operations in 16 crisis-ridden countries" and has received "less than half of the $9.5 billion it needs to carry out it humanitarian operations this year," VOA News reports (Schlein, 7/21).
› Verified 3 days ago
| Entity Name | Carson Tahoe Regional Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255360160 PECOS PAC ID: 1759284862 Enrollment ID: O20040128000187 |
News Archive
We're born with our brains prewired, but as information comes in from our environment, this circuitry is updated. A study from Boston Children's Hospital provides a new glimpse of how this happens: Brain cells known as microglia, tuned into the crosstalk between neurons, literally engulf unnecessary connections, known as synapses, and prune them away.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of EonC, the first extended-life primary cell (non-rechargeable) neurostimulator for the treatment of chronic pain.
The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
It is estimated that more than 1 billion individuals worldwide in 2005 had presbyopia, or age-related difficulty in seeing objects nearby, with an estimated 410 million with the condition unable to perform tasks requiring near vision, according to a report in the December issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
The U.N. on Tuesday said "it is running a record funding-shortfall of $4.8 billion for its aid operations in 16 crisis-ridden countries" and has received "less than half of the $9.5 billion it needs to carry out it humanitarian operations this year," VOA News reports (Schlein, 7/21).
› Verified 3 days ago
| Entity Name | Carson Tahoe Physician Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023265717 PECOS PAC ID: 1153479027 Enrollment ID: O20090502000046 |
News Archive
We're born with our brains prewired, but as information comes in from our environment, this circuitry is updated. A study from Boston Children's Hospital provides a new glimpse of how this happens: Brain cells known as microglia, tuned into the crosstalk between neurons, literally engulf unnecessary connections, known as synapses, and prune them away.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of EonC, the first extended-life primary cell (non-rechargeable) neurostimulator for the treatment of chronic pain.
The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
It is estimated that more than 1 billion individuals worldwide in 2005 had presbyopia, or age-related difficulty in seeing objects nearby, with an estimated 410 million with the condition unable to perform tasks requiring near vision, according to a report in the December issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
The U.N. on Tuesday said "it is running a record funding-shortfall of $4.8 billion for its aid operations in 16 crisis-ridden countries" and has received "less than half of the $9.5 billion it needs to carry out it humanitarian operations this year," VOA News reports (Schlein, 7/21).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Phil M Aldrich, MD Po Box 4540, Carson City, NV 89702-4540 Ph: (775) 882-0430 | Phil M Aldrich, MD 2874 N Carson St, Suite 200, Carson City, NV 89706-0251 Ph: (775) 445-7170 |
News Archive
We're born with our brains prewired, but as information comes in from our environment, this circuitry is updated. A study from Boston Children's Hospital provides a new glimpse of how this happens: Brain cells known as microglia, tuned into the crosstalk between neurons, literally engulf unnecessary connections, known as synapses, and prune them away.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of EonC, the first extended-life primary cell (non-rechargeable) neurostimulator for the treatment of chronic pain.
The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
It is estimated that more than 1 billion individuals worldwide in 2005 had presbyopia, or age-related difficulty in seeing objects nearby, with an estimated 410 million with the condition unable to perform tasks requiring near vision, according to a report in the December issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
The U.N. on Tuesday said "it is running a record funding-shortfall of $4.8 billion for its aid operations in 16 crisis-ridden countries" and has received "less than half of the $9.5 billion it needs to carry out it humanitarian operations this year," VOA News reports (Schlein, 7/21).
› Verified 3 days ago
Susan J Maturlo, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2874 N Carson St, Suite 120, Carson City, NV 89706 Phone: 775-445-7170 Fax: 775-687-8457 | |
Dr. David M Baker, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1470 Medical Pkwy, Suite 160, Carson City, NV 89703 Phone: 775-445-7650 Fax: 775-687-8457 | |
Dr. Stephen Michael Tann, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1470 Medical Parkway, Suite 160, Carson City, NV 89703 Phone: 775-445-7650 Fax: 775-882-4206 | |
Dr. Larry Angelo Pappas, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1600 Medical Pkwy, Carson City, NV 89703 Phone: 775-445-8000 | |
Dr. Christopher J Dipaolo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1470 Medical Pkwy, Suite 160, Carson City, NV 89703 Phone: 775-445-7650 Fax: 775-687-8457 | |
Richard I Yamamoto, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2874 N Carson St, Suite 200, Carson City, NV 89706 Phone: 775-445-7170 Fax: 775-883-0959 | |
Dr. Christopher W Forman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2874 N Carson St, Suite 200, Carson City, NV 89706 Phone: 775-445-7170 Fax: 775-883-0959 |